Starpharma Ret. on equity
What is the Ret. on equity of Starpharma?
The Ret. on equity of Starpharma Holdings Limited is -26.13%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on ASX compared to Starpharma
What does Starpharma do?
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel, a non-antibiotic therapy for the management and prevention of bacterial vaginosis. It also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, the company develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase II clinical trials, DEP cabazitaxel that is in Phase II clinical trial, and DEP irinotecan that is in phase II clinical trials for the treatment of cancer; oncology programs, such as DEP radiopharmaceuticals, DEP HER-2 ADC, and DEP gemcitabine; DEP non-oncology candidates; and DEP AZD0466, which is in Phase I/II clinical trials to treat haematological tumours. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Companies with ret. on equity similar to Starpharma
- FYI Resources has Ret. on equity of -26.22%
- Dorel Industries has Ret. on equity of -26.21%
- Justify Capital has Ret. on equity of -26.19%
- AuKing Mining has Ret. on equity of -26.18%
- Shanghai Junshi Biosciences Co has Ret. on equity of -26.16%
- Chariot Oil & Gas has Ret. on equity of -26.16%
- Starpharma has Ret. on equity of -26.13%
- Ted Baker Plc has Ret. on equity of -26.12%
- Eaton Vance Enhanced Equity Income Fund II has Ret. on equity of -26.12%
- CGX has Ret. on equity of -26.11%
- Lee Hing Development has Ret. on equity of -26.10%
- Battery Road Capital has Ret. on equity of -26.09%
- Auto Italia has Ret. on equity of -26.09%